Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
896.00    2.00 (0.22%)
Bid:
894.00
Ask:
900.00
Spread: 6.00 (0.671%)
Market Cap: £487.52m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Dividend Declaration

15 Jul 2025 15:31

RNS Number : 1716R
JPMorgan Claverhouse IT PLC
15 July 2025
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the 'Company')

 

Second quarterly interim dividend

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

 

The Directors have declared that a second quarterly interim dividend of 8.40 pence per share for the year ending 31st December 2025 will be paid on 1st September 2025 to shareholders on the register at the close of business on 25th July 2025. The ex-dividend date will be 24th July 2025.

 

As announced in the Annual Report, the Board intends to raise the first three quarterly interim dividends in 2025 to 8.40p per share, from 8.25p per share in the previous financial year, subject to any unforeseen factors and the financial position and performance of the Company at the relevant time.

 

The Company has increased its total annual dividend for 52 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to, or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services PLC.

 

The key dates relating to this dividend are given below:

 

Ex-dividend date

24th July 2025

Record date

25th July 2025

Last date for DRIP election

8th August 2025

Payment date

1st September 2025

 

 

15th July 2025

 

For further information, please contact:

 Anmol Dhillon

 JPMorgan Funds Limited

 Company Secretary

 0800 20 40 20 (or +44 1268 44 44 70)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUUWMUPAGCA
Date   Source Headline
14th Apr 202610:54 amRNSNet Asset Value(s)
13th Apr 202612:07 pmRNSGearing announcement
13th Apr 202611:12 amRNSNet Asset Value(s)
10th Apr 202611:07 amRNSNet Asset Value(s)
9th Apr 202611:06 amRNSNet Asset Value(s)
8th Apr 202610:27 amRNSNet Asset Value(s)
7th Apr 20265:35 pmRNSNOTIFICATION OF CROSS HOLDING
7th Apr 202612:24 pmRNSGearing Announcement
7th Apr 202611:38 amRNSNet Asset Value(s)
2nd Apr 202611:19 amRNSNet Asset Value(s)
1st Apr 202611:48 amRNSNet Asset Value(s)
1st Apr 202610:10 amRNSTotal Voting Rights
31st Mar 20264:52 pmRNSTransaction in Own Shares
31st Mar 202611:22 amRNSNet Asset Value(s)
30th Mar 20265:14 pmRNSTransaction in Own Shares
30th Mar 202612:06 pmRNSGearing Announcement
30th Mar 202611:30 amRNSNet Asset Value(s)
27th Mar 202611:26 amRNSNet Asset Value(s)
26th Mar 202611:17 amRNSNet Asset Value(s)
25th Mar 202610:56 amRNSNet Asset Value(s)
25th Mar 20267:00 amRNSDirectorate change
25th Mar 20267:00 amRNSDividend Declaration
25th Mar 20267:00 amRNSFinal Results
24th Mar 202611:29 amRNSNet Asset Value(s)
23rd Mar 20261:38 pmRNSGearing Announcement
23rd Mar 202610:58 amRNSNet Asset Value(s)
20th Mar 202611:28 amRNSNet Asset Value(s)
19th Mar 202610:46 amRNSNet Asset Value(s)
18th Mar 202611:02 amRNSNet Asset Value(s)
17th Mar 202611:12 amRNSNet Asset Value(s)
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:18 amRNSNet Asset Value(s)
13th Mar 20265:14 pmRNSTransaction in Own Shares
13th Mar 202611:27 amRNSNet Asset Value(s)
11th Mar 20264:15 pmRNSTen Largest Investments
11th Mar 20264:15 pmRNSTen Largest Investments
11th Mar 202611:16 amRNSNet Asset Value(s)
9th Mar 20265:09 pmRNSTransaction in Own Shares
9th Mar 202611:13 amRNSGearing announcement
9th Mar 202610:44 amRNSNet Asset Value(s)
6th Mar 202611:32 amRNSNet Asset Value(s)
5th Mar 202610:54 amRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:27 amRNSNet Asset Value(s)
2nd Mar 202612:57 pmRNSGearing Announcement
2nd Mar 202611:25 amRNSNet Asset Value(s)
27th Feb 202610:46 amRNSNet Asset Value(s)
26th Feb 202610:38 amRNSNet Asset Value(s)
25th Feb 202610:20 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.